ArticleNPJ digital medicine2026
Algorithm-driven HPV vaccine allocation paradigm for cervical cancer elimination targeting the Chinese population.
Article in NPJ digital medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
This study identifies optimal, fiscally sustainable HPV vaccination strategies for China using Bayesian optimization and transmission dynamics modeling. By integrating a demographic-based HPV transmission model with a decision-analysis framework, we simulated cervical cancer burden across varying time horizons (30-100 years). Our budget impact analysis, incorporating willingness-to-pay data from a multi-center contingent valuation survey of 787 parents, reveals critical funding dynamics. We found that achieving cervical cancer elimination within 40 years necessitates a 23.97% vaccination coverage among 15-17-year-old girls using the domestic nonavalent vaccine. Conversely, a rapid 30-year elimination target requires 76.66% coverage. At current market prices, autonomous consumer demand falls short, exposing a ¥35.93 billion funding gap for the 40-year target. To mitigate these financial barriers and ensure long-term fiscal resilience, we propose a tripartite financing mechanism-allocating costs among consumers (45.90%), the government (26.19%), and medical insurance (27.91%). These algorithm-driven findings provide an actionable, evidence-based framework for optimizing multi-party health financing and accelerating cervical cancer elimination in China.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.